Doravirine
Pifeltro (doravirine) is a small molecule pharmaceutical. Doravirine was first approved as Pifeltro on 2018-08-30. It is used to treat hiv-1 in the USA. It has been approved in Europe to treat HIV infections. Delstrigo's patent is valid until 2031-10-07 (FDA).
| Trade Name | Pifeltro |
|---|---|
| Common Name | Doravirine |
| Indication | hiv infections, hiv-1 |
| Drug Class | Antivirals: non-nucleoside reverse transcriptase inhibitors, not benzoxazinone derivatives |
